A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3540378 in Adults with Worsening Chronic Heart Failure with Preserved Ejection Fraction (HFpEF)

Project: Research project

Project Details

StatusActive
Effective start/end date8/30/23 → 8/29/28

Funding

  • Eli Lilly: $22,260.00